Tenon Medical Notifies Nasdaq of Stockholders' Equity Compliance

What Happened

• Tenon Medical, Inc. (TNON) announced on July 20, 2026 that Nasdaq notified the company on July 17, 2026 it had regained compliance with Nasdaq’s Stockholders’ Equity Rule. The company had previously filed a Form 8-K on July 10, 2026 stating it believed it satisfied Listing Rule 5550(b)(1) after completing a $4.2 million public offering of common stock and warrants on July 1, 2026. The company attached a press release dated July 20, 2026 to this 8-K.

Key Details

• Nasdaq notice received: July 17, 2026.
• Company disclosure dates: July 1, 2026 (closing of $4.2M public offering); July 10, 2026 (prior 8-K reporting belief of compliance); July 20, 2026 (press release and current 8-K).
• Amount raised: $4.2 million from public offering of common stock and warrants.
• Conditional status: Nasdaq’s notice is contingent — if Tenon fails to evidence compliance when it files its Form 10-Q for the quarter ending September 30, 2026, the company may be subject to delisting (with appeal rights).

Why It Matters

• This update addresses a prior listing compliance concern by reporting the company has taken capital-raising steps that Nasdaq views as restoring required stockholders’ equity. For investors, the filing highlights both reduced immediate delisting risk and a near-term deadline: the company must document compliance in its September 30, 2026 Form 10-Q or face potential delisting proceedings.